drugset / Trial / NCT02034604
Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to evaluate efficacy and safety of naftopidil in patient with neurogenic lower urinary tract dysfunction not caused by benign prostatic hyperplasia.
Timeline
- Start
- 2013-12
- Primary completion
- 2016-12
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naftopidil | Small molecule | — | — |
| Comparator | Tamsulosin | Other / unclassified | — | — |
Indications
No indication recorded.